Asenapine Maleate + Fluvoxamine Interaction
Moderateinteraction on record
Description
Strong CYP1A2 inhibitor that increases asenapine exposure. Full therapeutic dose expected to cause greater increase in asenapine exposure.
Mechanism
CYP1A2 inhibition
Source: NLP:asenapine maleate